Search research articles
Contact Us
Filters
Showing results (1-10 of 367) with videos related to
Page
of 37
Sort By:
Polish Archives of Internal Medicine
|
November 28, 2024
Oral anticoagulation in patients with atrial fibrillation and advanced chronic kidney disease: additional kidney benefits beyond stroke prevention
Reinhold Kreutz
Journal of Thrombosis and Thrombolysis
|
December 3, 2013
A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
Reinhold Kreutz
Current Clinical Pharmacology
|
November 14, 2013
Pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor
Reinhold Kreutz
MMW Fortschritte Der Medizin
|
July 3, 2016
[Not Available]
Reinhold Kreutz
Fundamental & Clinical Pharmacology
|
August 19, 2011
Pharmacodynamic and pharmacokinetic basics of rivaroxaban
Reinhold Kreutz
Current Hypertension Reports
|
February 20, 2004
Pharmacogenetics of antihypertensive drug response
Reinhold Kreutz
Krankenpflege Journal
|
March 7, 2006
[Value of combination therapy in treatment of hypertension]
Reinhold Kreutz
Blood Pressure
|
October 28, 2020
Professor Giuseppe Mancia receives the Excellence Research Award of the Council on Hypertension of the American Heart Association
Reinhold Kreutz
Lancet (London, England)
|
August 30, 2025
Better blood pressure control with predictable drug dosing
Mattias Brunström, Reinhold Kreutz
Journal of the American College of Cardiology
|
February 11, 2026
Beyond the RAAS: The Search for Novel Antihypertensive Therapies: A Needle in the Haystack?
Reinhold Kreutz, Mattias Brunström
Page
of 37
Search research articles
Search
Showing results (1-10 of 367) with videos related to
Sort By:
Page
of 37
Polish Archives of Internal Medicine
|
November 28, 2024
Oral anticoagulation in patients with atrial fibrillation and advanced chronic kidney disease: additional kidney benefits beyond stroke prevention
Reinhold Kreutz
Journal of Thrombosis and Thrombolysis
|
December 3, 2013
A clinical and pharmacologic assessment of once-daily versus twice-daily dosing for rivaroxaban
Reinhold Kreutz
Current Clinical Pharmacology
|
November 14, 2013
Pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor
Reinhold Kreutz
MMW Fortschritte Der Medizin
|
July 3, 2016
[Not Available]
Reinhold Kreutz
Fundamental & Clinical Pharmacology
|
August 19, 2011
Pharmacodynamic and pharmacokinetic basics of rivaroxaban
Reinhold Kreutz
Current Hypertension Reports
|
February 20, 2004
Pharmacogenetics of antihypertensive drug response
Reinhold Kreutz
Krankenpflege Journal
|
March 7, 2006
[Value of combination therapy in treatment of hypertension]
Reinhold Kreutz
Blood Pressure
|
October 28, 2020
Professor Giuseppe Mancia receives the Excellence Research Award of the Council on Hypertension of the American Heart Association
Reinhold Kreutz
Lancet (London, England)
|
August 30, 2025
Better blood pressure control with predictable drug dosing
Mattias Brunström, Reinhold Kreutz
Journal of the American College of Cardiology
|
February 11, 2026
Beyond the RAAS: The Search for Novel Antihypertensive Therapies: A Needle in the Haystack?
Reinhold Kreutz, Mattias Brunström
Page
of 37